These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

969 related items for PubMed ID: 22857268

  • 1. GnRH-agonist ovulation trigger in patients undergoing controlled ovarian hyperstimulation for IVF with ultrashort flare GnRH-agonist combined with multidose GnRH-antagonist protocol.
    Orvieto R, Nahum R, Zohav E, Liberty G, Anteby EY, Meltcer S.
    Gynecol Endocrinol; 2013 Jan; 29(1):51-3. PubMed ID: 22857268
    [Abstract] [Full Text] [Related]

  • 2. A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.
    Orvieto R.
    J Ovarian Res; 2015 Nov 04; 8():69. PubMed ID: 26536862
    [Abstract] [Full Text] [Related]

  • 3. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
    Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C.
    Fertil Steril; 2008 Jan 04; 89(1):84-91. PubMed ID: 17462639
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
    Yang S, Chen XN, Qiao J, Liu P, Li R, Chen GA, Ma CH.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr 04; 47(4):245-9. PubMed ID: 22781108
    [Abstract] [Full Text] [Related]

  • 5. Ultrashort flare GnRH agonist combined with flexible multidose GnRH antagonist for patients with repeated IVF failures and poor embryo quality.
    Orvieto R, Nahum R, Rabinson J, Gemer O, Anteby EY, Meltcer S.
    Fertil Steril; 2009 Apr 04; 91(4 Suppl):1398-400. PubMed ID: 18675974
    [Abstract] [Full Text] [Related]

  • 6. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
    Shavit T, Ellenbogen A, Michaeli M, Kartchovsky E, Ruzov O, Shalom-Paz E.
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug 04; 179():46-50. PubMed ID: 24965979
    [Abstract] [Full Text] [Related]

  • 7. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH, Wu FS, Lee RK, Li SH, Lin SY, Hwu YM.
    Fertil Steril; 2013 Nov 04; 100(5):1296-302. PubMed ID: 23993928
    [Abstract] [Full Text] [Related]

  • 8. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
    Bodri D, Guillén JJ, Galindo A, Mataró D, Pujol A, Coll O.
    Fertil Steril; 2009 Feb 04; 91(2):365-71. PubMed ID: 18367175
    [Abstract] [Full Text] [Related]

  • 9. Substituting HCG with GnRH agonist to trigger final follicular maturation--a retrospective comparison of three different ovarian stimulation protocols.
    Orvieto R, Rabinson J, Meltzer S, Zohav E, Anteby E, Homburg R.
    Reprod Biomed Online; 2006 Aug 04; 13(2):198-201. PubMed ID: 16895632
    [Abstract] [Full Text] [Related]

  • 10. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
    Iliodromiti S, Blockeel C, Tremellen KP, Fleming R, Tournaye H, Humaidan P, Nelson SM.
    Hum Reprod; 2013 Sep 04; 28(9):2529-36. PubMed ID: 23873146
    [Abstract] [Full Text] [Related]

  • 11. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric study.
    Griesinger G, Schultz L, Bauer T, Broessner A, Frambach T, Kissler S.
    Fertil Steril; 2011 May 04; 95(6):2029-33, 2033.e1. PubMed ID: 21371705
    [Abstract] [Full Text] [Related]

  • 12. [Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome].
    Zhu RR, Xiao SQ, Zhao JZ, Lin J, Wang PY, Jin CC, Jin WM.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov 04; 48(11):833-7. PubMed ID: 24444560
    [Abstract] [Full Text] [Related]

  • 13. Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs.
    Orvieto R, Kruchkovich J, Rabinson J, Zohav E, Anteby EY, Meltcer S.
    Fertil Steril; 2008 Jul 04; 90(1):228-30. PubMed ID: 17681292
    [Abstract] [Full Text] [Related]

  • 14. What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?
    Orvieto R, Meltcer S, Homburg R, Nahum R, Rabinson J, Ashkenazi J.
    Fertil Steril; 2009 Apr 04; 91(4 Suppl):1466-8. PubMed ID: 18774558
    [Abstract] [Full Text] [Related]

  • 15. Controlled ovarian hyperstimulation using multi-dose gonadotropin-releasing hormone (GnRH) antagonist results in less systemic inflammation than the GnRH-agonist long protocol.
    Orvieto R, Volodarsky M, Hod E, Homburg R, Rabinson J, Zohav E, Anteby EY, Meltcer S.
    Gynecol Endocrinol; 2007 Apr 04; 23(8):494-6. PubMed ID: 17852411
    [Abstract] [Full Text] [Related]

  • 16. Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With "Genuine" Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF.
    Orvieto R, Kirshenbaum M, Galiano V, Elkan-Miller T, Zilberberg E, Haas J, Nahum R.
    Front Endocrinol (Lausanne); 2020 Apr 04; 11():182. PubMed ID: 32528403
    [Abstract] [Full Text] [Related]

  • 17. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis.
    Griesinger G, Diedrich K, Devroey P, Kolibianakis EM.
    Hum Reprod Update; 2006 Apr 04; 12(2):159-68. PubMed ID: 16254001
    [Abstract] [Full Text] [Related]

  • 18. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.
    Seyhan A, Ata B, Polat M, Son WY, Yarali H, Dahan MH.
    Hum Reprod; 2013 Sep 04; 28(9):2522-8. PubMed ID: 23633553
    [Abstract] [Full Text] [Related]

  • 19. Ovulation induction and luteal support with GnRH agonist in patients at high risk for hyperstimulation syndrome.
    Fusi FM, Arnoldi M, Bosisio C, Lombardo G, Ferrario M, Zanga L, Galimberti A, Capitanio E.
    Gynecol Endocrinol; 2015 Sep 04; 31(9):693-7. PubMed ID: 26527503
    [Abstract] [Full Text] [Related]

  • 20. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
    Vuong TN, Ho MT, Ha TD, Phung HT, Huynh GB, Humaidan P.
    Fertil Steril; 2016 Feb 04; 105(2):356-63. PubMed ID: 26523330
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.